Be Ready for the New Combo HIV Med Biktarvy
Biktarvy (bik-TAR-vee, bictegravir/emtricitabine/tenofovir alafenamide) will be a new first-line option for HIV.
Think of it as a complete HIV regimen in one pill.
Biktarvy combines a new integrase inhibitor, bictegravir...with two nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors (NRTIs), emtricitabine and tenofovir alafenamide.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote